Recently, a European Union supported secure messaging service for telemedicine has been unveiled which is designed to form the backbone of a pan-European remote diagnosis system.
Licore's Web Correspondent is a browser-based interface running on NT. The system is using 128-bit encryption to communicate information on specialist medical problems. Licore is one of several companies, which is sponsored by the European Union to become involved in the Medicate joint venture to create a telemedicine system.
A demonstration of the Medicate system showed how an asthma sufferer can breath into a device, measuring symptoms, in order to upload the results to Web Correspondent via modem. The information is transmitted to medical staff and specialists at any location via the Internet. Physicians access the site to download figures and review or manipulate the data before issuing a preliminary remote diagnosis.
The major aim is to spare the patients from having to make frequent hospital trips, but the system would also save on resources and paperwork. Medicate intends to build a European telemedicine infrastructure so that a wide range of medical problems can be dealt with on a remote basis, as has been stated by Licore.
Medicate will seek to sell the equipment and license the service to the health authorities, including the National Health Service in the United Kingdom, by arguing that health care will be improved at the same time that consultant and hospital overheads are reduced. The entire Medicate system is expected to be available in 18 months, according to Licore.